FINWIRES · TerminalLIVE
FINWIRES

JPMorgan Downgrades Fulcrum Therapeutics to Underweight From Overweight

By

Fulcrum Therapeutics (FULC) has an average rating of hold and mean price target of $4.88, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles